{{Rsnum
|rsid=11854484
|Gene=SLC28A2
|Chromosome=15
|position=45253280
|Orientation=plus
|GMAF=0.3315
|Gene_s=SLC28A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 13.3 | 46.0 | 40.7
| HCB | 86.7 | 12.6 | 0.7
| JPT | 91.9 | 8.1 | 0.0
| YRI | 81.4 | 18.6 | 0.0
| ASW | 75.4 | 22.8 | 1.8
| CHB | 86.7 | 12.6 | 0.7
| CHD | 86.2 | 12.8 | 0.9
| GIH | 28.7 | 43.6 | 27.7
| LWK | 71.6 | 24.8 | 3.7
| MEX | 44.8 | 37.9 | 17.2
| MKK | 81.4 | 18.6 | 0.0
| TSI | 17.6 | 44.1 | 38.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=23149444
|Title=Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment
}}

{{PMID Auto
|PMID=23195617
|Title=Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}